TAE Technologies is committed to creating a sustainable future for us all. We began our research into fusion energy nearly 20 years ago, and built our company with commercialization in mind. Our solution is clean, compact, affordable – and safe in every way. In short: Friendly Fusion.
We Call It Norman Because He Deserves it
- TAE Technologies latest generator is named after our late intellectual co-founder, Dr. Norman Rostoker.
- He envisioned the path to clean, commercial fusion energy nearly two decades ago. Today’s working machine is nearly identical to his original model.
- Since unveiling Norman in July 2017, we have performed over 3,000 experiments with the machine.
- Our current work with Norman is focused on plasma merging and field-reverse configurations (FRCs) to achieve optimal, scalable conditions for fusion.
From the Front Lines of Physics
Dispatches from TAE Technologies President, CTO and technology co-founder, Michl Binderbauer, and a behind the scenes look into our research. Learn more about our latest achievement in merging and colliding field-reverse configurations (FRCs) here.
June 21, 2019
As CEO of TAE Technologies, the world’s largest private fusion reactor company, Michl Binderbauer is one of those who believes that fusion power could be on the near horizon – and is using artificial intelligence co-developed with Google to help make it a reality.
July 19, 2018
TAE Technologies recently welcomed the Department of Energy and Secretary Rick Perry for a tour of our National Laboratory-scale platform, Norman. “It was an honor to host the Secretary and share with him our enthusiasm for the opportunities our fusion pathway can provide,” said CEO Michl Binderbauer.
July 17, 2018
TAE Technologies is proud to announce new executive appointments to lead the next phase of the company’s growth: Michl Binderbauer has been named Chief Executive Officer, assuming leadership from retiring CEO Dr. Steven Specker. Former GE Chairman and CEO Jeffrey R. Immelt joins the company’s Board of Directors.
March 12, 2018
TAE Technologies is proud to announce our first subsidiary company, TAE Life Sciences, dedicated to advancing the potential of Boron Neutron Capture Therapy (BNCT). BNCT is a promising cancer treatment for head and neck, glioblastoma multiforme (GBM) and other cancers that are difficult or impossible to treat with traditional methods. The new company leverages our fusion energy breakthroughs for the next generation BNCT platform, and is poised to reshape world of oncology.
Our Research Is Here To Help
In our pursuit of fusion energy, we’ve published many significant research reports and papers in peer-reviewed journals. Search over 150 papers, including experimental results and theoretical science, in our research library.